Brain Imaging Studies in Pathological Gambling by van Holst, Ruth J. et al.
Brain Imaging Studies in Pathological Gambling
Ruth J. van Holst & Wim van den Brink &
Dick J. Veltman & Anna E. Goudriaan
Published online: 30 July 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract This article reviews the neuroimaging research
on pathological gambling (PG). Because of the similarities
between substance dependence and PG, PG research has
used paradigms similar to those used in substance use
disorder research, focusing on reward and punishment
sensitivity, cue reactivity, impulsivity, and decision making.
This review shows that PG is consistently associated with
blunted mesolimbic-prefrontal cortex activation to nonspe-
cific rewards, whereas these areas show increased activa-
tion when exposed to gambling-related stimuli in cue
exposure paradigms. Very little is known, and hence more
research is needed regarding the neural underpinnings of
impulsivity and decision making in PG. This review
concludes with a discussion regarding the challenges and
new developments in the field of neurobiological gambling
research and comments on their implications for the
treatment of PG.
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Introduction
When gambling behavior becomes compulsive, starts to
interfere with relationships, and negatively affects social
activities or work, it is defined as pathological gambling
(PG). Although PG is classified as an impulse control
disorder in the DSM-IV, it is often regarded as a behavioral
or nonchemical addiction because of its genetic, endophe-
notypic, and phenotypic resemblances to substance depen-
dence. For example, diagnostic criteria for PG resemble
those of substance dependence, and both disorders show
similar comorbidity patterns [1], genetic vulnerabilities, and
responses to specific pharmacologic treatments [2].
Investigating PG as a model of addictive behavior is
attractive because it may reveal how addictive behaviors
can develop and affect brain function, without the con-
founding effects of (neurotoxic) substances. Moreover,
better understanding of the neurobiological basis of PG
could help improve treatment for this disorder.
Given the similarities between PG and substance depen-
dence,PGresearchhasmadeassumptionsandusedparadigms
similartothoseusedinsubstanceusedisorder(SUD)research.
Current addiction theories have identified four important
cognitive-emotional processes that are likely to be relevant
for PG as well. The first of these is reward and punishment
processing and its relation to behavioral conditioning. The
second process is increased salience of gambling cues that
oftenresultsin strong urges orcraving forgambling.Thethird
isimpulsivity because it has beenimplicated asa vulnerability
trait for acquiring PG and as a consequence of gambling
problems. The fourth process is impaired decision making
because pathological gamblers continue gambling in the face
of severe negative consequences.
Although neuropsychological studies in PG have con-
sistently reported aberrant function in these domains [3,
4￿￿], implementation of neuroimaging techniques has only
recently begun to elucidate the neurobiology of PG. In this
review, neuroimaging findings in PG are discussed using
the four processes just described as an organizing principle.
Based on the search criteria used in the recent review of
van Holst et al. [4￿￿], which included 10 neuroimaging
studies published since 2005, we updated this selection
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(ie, 2009–2010). Furthermore, we discuss challenges and
novel developments in the field of neurobiological gam-
bling research and comment on their implications for the
treatment of PG.
Reward and Punishment Sensitivity
Behavioral conditioning is a key process involved in the
development of gambling behavior because gambling
operates on a variable intermittent pattern of reinforcement
[5]. Differences in behavioral conditioning depend on
underlying reward and punishment sensitivity, which have
been studied in PG relatively often with neuroimaging
techniques.
Reuter et al. [6] compared functional MRI (fMRI) blood
oxygen level dependence (BOLD) responses associated with
reward and punishment events in 12 pathological gamblers
and 12 normal controls (NCs) using a guessing paradigm.
They reported lower ventral striatal and ventromedial
prefrontal cortex (VMPFC) activity in pathological gamblers
when they were receiving monetary gains compared with
controls. Comparable results were reported in a study by de
Ruiter et al. [7￿], who used an affective switching paradigm
to investigate the effects of reward and punishment on
subsequent behavior. Imaging data associated with monetary
gains showed that pathological gamblers (n=19) had lower
ventrolateral prefrontal cortex activation to monetary gain
than NCs (n=19). In addition, this study showed lower
sensitivity to monetary losses in pathological gamblers than
among NCs. Whereas Reuter et al. [6] found differences
predominantly in ventromedial portions of the prefrontal
cortex, de Ruiter and colleagues [7￿] reported differences
mainly in ventrolateral prefrontal regions. In their discussion,
de Ruiter et al. [7￿] suggested that their lack of VMPFC
findings was probably a result of signal loss caused by tissue
inhomogeneity in these regions.
Thus, pathological gamblers were found to have dimin-
ished ventral striatum and ventral prefrontal activation
during nonspecific rewarding and punishing events com-
pared with NCs [6, 7￿], implicating a blunted neurophys-
iologic response to rewards as well as to losses in
pathological gamblers. The reported diminished ventral
striatum activation in response to nonspecific rewarding
and punishing events found by Reuter et al. [6] is similar to
findings in SUDs [8, 9]. Moreover, most addiction theories
have stated that substance dependence is characterized by
decreased basal ganglia dopaminergic transmission predat-
ing the development of addictive behavior, and that
repeated drug use results in a further reduction of dopamine
(DA) transmission associated with diminished sensitivity to
rewarding stimuli [10]. In line with these theories, it has
been hypothesized that pathological gamblers are more
likely to seek rewarding events to compensate for a
preexisting anhedonic state comparable with that of
substance-dependent individuals [11]. However, from the
existing literature on PG, it is not yet clear whether
diminished reward and punishment sensitivity is a conse-
quence or a precursor of problem gambling.
Cue Reactivity
In addition to reward system dysfunction, a prominent
symptom of PG is the strong urge to gamble, which often
leads to a relapse in gambling behavior. Although craving
and cue reactivity have been extensively studied with
neuroimaging techniques in SUDs, only a few studies in
PG have been published.
The first fMRI study on gambling urges was published in
2003 [12]. While viewing a gambling video designed to
evoke emotional and motivational antecedents to gambling
(actors who mimicked emotional [eg, happy, angry] situa-
tions followed by the actor describing driving to and walking
through a casino and the feeling of gambling), participants
were asked to press a button when they experienced
gambling urges. During such episodes of increased craving,
the PG group (n=10) showed less activation in the cingulate
gyrus, (orbito)frontal cortex, caudate, basal ganglia, and
thalamic areas compared with the NC group (n=11).
Recently, the authors reanalyzed their 2003 data to determine
whether motivational processing in pathological gamblers
(n=10) and cocaine users (n=9) differed from that of
recreational gamblers (n=11) and NCs (n=6) not using
cocaine [13]. Viewing of addiction-related scenarios com-
pared with neutral scenarios resulted in increased activity in
the ventral and dorsal anterior cingulate cortex and right
inferior parietal lobule, with relatively decreased activity in
pathological gamblers compared with recreational gamblers,
and relatively increased activity in cocaine users compared
with NCs. These findings therefore indicate opposite effects
in individuals with an SUD compared with those with a
behavioral addiction.
In contrast, an fMRI cue reactivity study by Crockford et
al. [14] found a higher BOLD response in the right
dorsolateral prefrontal cortex (DLPFC), right inferior
frontal gyrus, medial frontal gyrus, left parahippocampal
region, and left occipital cortex in response to gambling
stimuli in pathological gamblers (n=10) compared with
NCs (n=11). In addition, the dorsal visual processing
stream was activated in pathological gamblers when they
were viewing gambling movies, whereas the ventral visual
stream was activated in controls when they viewed these
movies. The authors argued that brain regions activated in
pathological gamblers compared with NCs predominantly
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which is associated with conditional responses.
In a recent study, Goudriaan et al. [15] showed similar cue
reactivity-related brain activations as reported by Crockford
et al. [14] in pathological gamblers (n=17) compared with
NCs (n=17). In this fMRI study, participants viewed
gambling pictures and neutral pictures while being scanned.
When viewing gambling pictures versus neutral pictures,
higher bilateral parahippocampal gyrus, right amygdala, and
right DLPFC activity was found in problem gamblers relative
to NCs. Furthermore, a positive relationship was found
between subjective craving for gambling after scanning in
problem gamblers and BOLD activation in the ventrolateral
prefrontal cortex, left anterior insula, and left caudate head
when viewing gambling pictures versus neutral pictures.
Finally, in a recent gambling paradigm study, 12 problems
gamblers and 12 frequent (nonproblem) gamblers were asked
to play a blackjack gambling game while fMRI scans were
obtained [16]. The game consisted of trials with a high risk
of losing and trials with a low risk of losing. Problem
gamblers showed a signal increase in thalamic, inferior
frontal, and superior temporal regions during high-risk trials
and a signal decrease in these regions during low-risk trials,
whereas the opposite pattern was observed in frequent
gamblers. Miedl and colleagues [16] argued that the
frontal-parietal activation pattern noted during high-risk trials
compared with low-risk trials in problem gamblers reflects a
cue-induced addiction memory network that is triggered by
gambling-related cues. They suggested that high-risk sit-
uations might serve as an addiction cue in problem gamblers,
whereas the low-risk situation signifies a “safe” hit in
frequent gamblers. Interestingly, problem gamblers showed
higher activity in dorsolateral prefrontal and parietal lobes
compared with frequent gamblers while winning as com-
pared with losing money, a network generally associated
with executive function. However, activity patterns in limbic
regions while winning compared with losing money were
similar, which is at odds with earlier findings of reward
processing in the studies by Reuter et al. [6] and de Ruiter et
al. [7￿]. Differences in the employed paradigms could
explain the dissimilarities between these studies: whereas in
the blackjack paradigm of Miedl and colleagues [16], the
winning result had to be calculated by the participants
(calculating the card values) before they realized that a win
or loss was experienced, in the studies by Reuter et al. [6]
and de Ruiter et al. [7￿], wins or losses were displayed on the
screen and thus experienced immediately. Therefore, in the
study by Miedl et al. [16], the relatively high stimulus
complexity and cognitive elements in reward and loss
experiencing may have influenced reward processing and
diminished the potential to find group differences.
Thus, cue reactivity studies in PG have so far reported
conflicting results. It should be noted, however, that the
findings of Potenza et al. [12, 13]a r ed i f f i c u l tt oi n t e r p r e t
because of the complex emotional movies used to elicit
craving for gambling. On the other hand, the increased
activity in response to gambling cues in the prefrontal cortex,
parahippocampal regions, and occipital cortex reported by
Crockford et al. [14], Goudriaan et al. [15], and Miedl et al.
[16] is consistent with results from cue reactivity paradigms
in SUD studies [17, 18]. However, in contrast to SUD
studies, enhanced limbic activation during cue reactivity
paradigms in gambling was only reported in one of the
gambling cue reactivity studies [15]. Future research should
focus on the type of stimuli that elicit the most powerful cue
reactivity (eg, pictures vs movies). One aspect that may
diminish the power to detect differences in cue reactivity in
PG studies as opposed to SUD studies is that gambling may
involve a diversity of gambling activities (eg, blackjack, slot
machines, horse racing), whereas cue reactivity to a
substance is more specific for the targeted substance (eg,
cocaine, marijuana) and may therefore elicit limbic brain
activity in most SUD participants. Selecting specific gam-
bling types for cue reactivity stimuli and limiting participant
inclusion to a specific gambling pathology may result in a
better matching of cues and PG pathology and thus result in
more robust brain activations in response to cues in PG.
Impulsivity in Pathological Gambling
Impulsivity is often equated with disinhibition, a state during
which top-down control mechanisms that normally suppress
automatic or reward-driven responses are inadequate to meet
currentdemands[19]. Disinhibition has received considerable
attention in addiction research in recent years because it has
been recognized as an endophenotype of individuals at risk
of SUD and PG [20]. Another aspect of impulsivity that is
frequently addressed in neurocognitive studies is delay
discounting: choosing for immediate smaller rewards instead
of delayed larger rewards. This aspect is discussed in the next
section on decision making. Unfortunately, neuroimaging
studies investigating the neural correlates of impulsivity/
disinhibition in PG are scarce.
In the only fMRI study published to date, Potenza et al.
[21] used a Stroop color–word task to assess cognitive
inhibition—that is, inhibition of an automatic response
(congruent stimulus; reading a word) compared with
naming the color in which the word is printed (incongruent
stimulus)—in 13 pathological gamblers and 11 NCs.
Pathological gamblers showed lower activation in the left
middle and superior frontal gyri compared with the NC
group during processing of incongruent versus congruent
stimuli.
In summary, although several neuropsychological stud-
ies have indicated higher impulsivity in pathological
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study on inhibition has been published. Therefore, addi-
tional neuroimaging studies are warranted, preferably with
larger populations and assessment of a variety of impulsiv-
ity measures in pathological gamblers.
Decision Making in Pathological Gambling
Pathological gamblers and SUD patients exhibit a pattern of
decisionmakingcharacterizedbyignoringlong-termnegative
consequences to obtain immediate gratification or relief from
uncomfortable states associated with their addiction [24]. A
variety of cognitive and emotional processes may affect
decision making. Risk taking, experiencing and evaluating
immediate versus delayed wins and losses, and impulsivity
have been found to contribute to the multifaceted concept of
decision making [25]. In addition, executive dysfunctions—
mainly diminished cognitive flexibility—have been associ-
ated with impairments in decision making [26].
In a recent event-related potential (ERP) study [27],
neurophysiologic correlates of decision making during a
blackjack game were measured. Twenty problem gamblers
and 21 NCs played a computerized blackjack game and had
to decide if they would “hit” or “sit” a card to arrive as
close as possible to, but not greater than 21 points. At the
critical score of 16 points, problem gamblers decided more
often than NCs to continue playing. Furthermore, problem
gamblers showed greater positive amplitude in the ERPs,
modelled by a dipole in the anterior cingulate cortex, than
NCs after successful “hit” decisions at 16. Thus, gamblers
showed more risk-taking behavior coupled with a stronger
neural response to (infrequent) successful outcomes of this
behavior compared with NCs. Interestingly, no neurophys-
iologic differences were observed between groups during
loss trials.
Until now, no other neuroimaging studies focusing on
decision-making processes in pathological gamblers have
been published. However, one fMRI study used a modified
version of the Iowa Gambling Task (IGT) to investigate
decision-making performance in NCs (n=16), individuals
with substance dependence (SD; n=20) and substance-
dependent individuals with comorbid gambling problems
(SDPG; n=20) [28]. The IGT was created to mimic real life
decision making [29]. Participants were presented with four
virtual decks of cards on a computer screen from which
they had to choose a card. Every card drawn would result in
a reward, but occasionally, a card would result in a loss.
Hence, some decks would lead to losses in the long run,
and others would lead to gains. The goal of the game was to
win as much money as possible. Although SDPGs tended
to perform better than SDs and NCs, these differences were
not statistically significant. SD and SDPG individuals
showed lower VMPFC activity compared with NCs when
performing the IGT. Furthermore, the SD group showed
less right superior frontal cortex activity during decision
making than the SDPG and NC groups. The authors
concluded that greater right superior frontal cortex activity
in SDPGs compared with SDs may reflect hypersensitivity
to gambling cues, because the IGT resembles a gambling
game. Unfortunately, the study did not include a patho-
logical gambler group without comorbid SUDs. These
results suggest that comorbid PG is not associated with an
added impairment in decision making in SD, a finding
inconsistent with a neurocognitive study of pathological
gamblers, SUDs, and NCs [23]. These incongruent
findings could be explained by the fact that Tanabe et al.
[28] used a modified version of the IGT that prevented
successive choices from a particular deck, thereby facili-
tating correct choices in the SD groups by eliminating the
need for cognitive flexibility that is likely to be defective
in pathological gamblers [26, 30].
Conclusions
The reviewed studies indicate that pathological gamblers
show decreased BOLD responses to nonspecific reward-
ing and punishing stimuli in the ventral striatum and
VMPFC [6, 7￿]. Notably, such blunted responses were not
observed in problem gamblers playing a more realistic
gambling game during the winning and losing of money
[16]. Three of four neuroimaging studies on cue reactivity
in pathological gamblers showed increased brain activa-
tion to gambling-related stimuli [14–16], whereas results
from the other study, which reported diminished brain
activation during a craving paradigm, were difficult to
interpret due to the complex stimulus paradigm used [12,
13]. The neurobiological mechanisms underlying abnor-
mal cue reactivity in pathological gamblers are therefore
not yet clear, and the same is true for the observed
increased impulsivity and disinhibition in pathological
gamblers. In addition, whereas a large number of neuro-
cognitive studies on impulsivity have indicated that
pathological gamblers are impaired in several inhibitory
processes (eg, filtering irrelevant information, inhibiting
ongoing responses, and delay discounting [4￿￿]), to date,
only one fMRI study on Stroop interference in patholog-
ical gamblers has been published [21]. Similarly, although
neurocognitive studies have indicated impaired decision
making among pathological gamblers [4￿￿], which is
consistent with findings in substance dependence [31],
only one ERP study on decision making in pathological
gamblers is currently available [27]. This latter study
indicated that problem gamblers displayed more risk-
taking behavior during gambling than NCs, and that
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activity in the anterior cingulate cortex. Finally, an fMRI
study investigating decision making using the IGT
indicated lower superior frontal cortex activity during
decision making in substance-dependent individuals with
gambling problems.
Clinical Implications
Although the overall number of neuroimaging studies in
pathological gamblers is still modest, fMRI studies have
consistently shown diminished activity in the mesolimbic
pathways in pathological gamblers comprising the ventral
striatum, amygdala, and VMPFC when problem gamblers
are dealing with reward and loss processing, but not when
they are in a gambling situation. These brain circuits are
thought to play an important role in integrating emotional
processing and behavioral consequences in healthy indi-
viduals. Because the VMPFC depends on DA projections
from other limbic structures to integrate information,
impaired DA transmission may underlie VMPFC dysfunc-
tion in pathological gamblers. However, many other
neurotransmitter systems are probably also engaged and
may interact during the processing of positive and negative
feedback. For example, opiates are known to increase DA
release in the brain reward pathways, and opiate antagonists
that decrease dopamine release (eg, naltrexone and nalme-
fene), have been found to reduce reward sensitivity and
probably increase punishment sensitivity [32]. This may be
the reason why opiate antagonists are more effective in
treating PG than placebo [33]. The effectiveness of opiate
antagonists indicates that targeting the reward system of the
brain may be a fruitful strategy in battling craving urges in
PG, similar to studies in alcohol and amphetamine
dependence [34]. Correspondingly, pharmacologic agents
modulating glutamate function (eg, N-acetylcysteine) with
known effects on the reward system also have been
effective in reducing gambling behavior in pathological
gamblers [35].
Impulsivity and impaired impulse control have been
targeted by selective serotonin reuptake inhibitors (SSRIs)
in impulse control disorders [36]. SSRI treatment has
yielded mixed results in pathological gamblers [36].
However, the presence or absence of a comorbid condition
often may shape the effectiveness of medication used to
treat PG. Whereas SSRIs such as fluvoxamine may be
effective in treating pathological gamblers with comorbid
depression or an obsessive-compulsive spectrum disorder,
they may not be the treatment of choice in pathological
gamblers with comorbid attention-deficit/hyperactivity dis-
order. Medications to improve decision making and
executive function are less well-established, probably
because of the complexity of these functions. Therefore,
the potential efficacy of cognitive enhancers such as
modafinil will have to be substantiated in future PG
medication studies [37]. Cognitive-behavioral therapy is
also effective in treating PG [38]. Future research should
clarify whether a combination of pharmacotherapy and
psychological treatment will lead to more sustained
remission rates in PG than either therapy alone.
Future Directions
Neurocognitive similarities and comparable pharmacologic
responsiveness in PG and SUDs seem to point to a common
vulnerability to addictive behaviors, and perhaps similar
pathological pathways underlying PG and SUDs. These
similarities provide a rationale to change the classification
of PG as an impulse control disorder to a new classification
of PG as a behavioral addiction in the DSM-V. However,
more research is needed to elucidate which neurocognitive
similarities and differences exist between SUDs and PG,
and studies directly comparing these disorders to each other
and to NC groups are evidently needed.
Furthermore, similar to methods used in SUD research,
future PG research combining pharmacologic challenges
with neuroimaging techniques may aid in unravelling the
neurobiological mechanisms of PG. For example, naltrex-
one could be used to manipulate opiate function in an fMRI
study on reward and punishment sensitivity, cue reactivity,
and craving.
Using “state-of-the-art” neuromodulation techniques
such as repetitive transcranial magnetic stimulation (rTMS)
could further illustrate the involvement of various brain
regions found in fMRI paradigms in gambling behavior.
For example, the key role of the DLPFC in preventing
relapse behavior was supported by an rTMS study
demonstrating that high-frequency DLPFC stimulation in
former smokers resulted in lower relapse rates and craving
for smoking compared with former smokers who received
sham rTMS [39]. Moreover, rTMS of the prefrontal cortex
was shown to change prefrontal function in addictive
disorders [40], although long-term effects on relapse are
less well-established. Using such designs could inform us
about localization of brain functions critically involved in
addictive behavior and eventually offer new treatment
options for PG.
Another interesting approach is the application of
neurofeedback in PG. By training individuals to change
specific brain activity patterns, we can test to determine
how this affects gambling behavior. This technique has
already been implemented in the treatment of attention-
deficit/hyperactivity disorder [41] and could be effective in
PG as well. For example, studies have indicated abnormal
prefrontal function in PG [6, 7￿, 21], and neurofeedback
training can be focused on normalizing frontal electroen-
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tion, executive functions may be trained, which may result
in improved cognitive control and, hence, diminished
likelihood of relapse when craving occurs.
Interestingly, a growing number of studies have reported
the development of PG during treatment of Parkinson’s
disease (PD). PD is characterized by loss of dopaminergic
neurons in the mesolimbic and mesocortical networks, and
treatment with DA agonists has been associated with
reward-seeking behaviors such as PG, compulsive shop-
ping, and disinhibition [42]. These behaviors likely reflect
modulation of reward circuitry functions by dopaminergic
drugs. Neuroimaging studies have reported decreased
activation in the mesolimbic pathway during monetary
gains in PD [43], similar to findings in PG and other
addictions. In addition, lower D2/D3 binding was reported
in a positron emission tomography study in PD with
comorbid PG compared with a control group with PD only
[44￿]. Furthermore, Eisenegger et al. [45￿] found that
healthy individuals who carry at least one copy of the 7-
repeat DRD4 DA receptor allele showed an increased
gambling propensity after dopaminergic stimulation with
L-DOPA. These findings demonstrate that genetic variation
in the DRD4 gene can determine an individual’s gambling
behavior in response to a dopaminergic drug challenge.
These observations are consistent with a reward deficiency
syndrome [46]. This postulates a chronic hypodopaminer-
gic state rendering individuals vulnerable to addictions by
triggering a drive for rewarding substances or behaviors to
boost low dopaminergic activity in the brain’s reward
circuitry. Future research investigating dopaminergic dysre-
gulation and interactions with genetic variations in PD
patients with and without PG may contribute to our
understanding of neurophysiologic factors predisposing
individuals to addictive behaviors.
Additional studies are similarly needed to investigate
expectancy values in pathological gamblers to explain
abnormal reward and punishment sensitivity, as these
abnormalities could be related to aberrant expectations
rather than to the actual experiences of reward and loss. For
example, a gambler may become biased in his or her
expectations of chances of winning because being in a
gambling situation provokes cue reactivity in the brain,
heightening DA release in the mesolimbic circuit. The
associated enhanced DA signalling could trigger a disrup-
tion of the correct expectancy coding because phasic DA
changes are crucial for expectancy coding [47]. Thus, by
enhanced cue reactivity, expectations are erroneously coded
and could contribute to continuation of gambling despite
heavy losses. In addition, abnormal expectancy values
could be influenced by cognitive distortions, such as
erroneous beliefs regarding the probability of winning [48].
Gambling games are thought to foster certain features
that may exaggerate confidence of one’s chances of
winning, thereby stimulating gambling propensity. In a
recent fMRI study, Clark et al. [49￿￿] investigated two of
these characteristics: personal control over the game and
the “near-win” event in NCs. Near-win events are events
in which unsuccessful outcomes are proximal to the
jackpot, such as when two cherries are displayed on the
slot machine pay line, and the last cherry ends up one
position below or above the pay line. Interestingly, near-
win outcomes activated ventral striatal and insula regions
that also responded to monetary wins. Such findings may
provide insights into the underlying mechanisms respon-
sible for the continuation of gambling behavior in spite of
the notion that one will lose money over time. Future
research should elaborate on these findings to help us
further understand the transition of gambling to problem
gambling and the addictive potential of certain game
characteristics.
A final area for future development is the subject of
resistance to the development of addictive behaviors.
Blaszczynski and Nower [5] described a class of problem
gamblers without comorbidities and minimal pathology.
This less severe gambling group was also thought to be
able to overcome their gambling problems without thera-
peutic interventions. Studying different subgroups of
pathological gamblers may yield insight into the neuropsy-
chological functions that are protective against the progres-
sion of problem gambling and/or against relapse. The
neurobiological factors that are clearly involved in PG and
that may influence the course of PG are executive
functions, including decision making and impulsivity; cue
reactivity; reward sensitivity; and erroneous perceptions.
From the review of neuroimaging studies, it is clear that the
neuronal background of these functions has not yet been
identified in detail. However, these neurobiological vulner-
abilities are likely to influence the course of PG in
combination with psychological factors, such as subjective
craving and coping skills; environmental factors (eg, the
vicinity of gambling opportunities); and genetic factors.
How these factors interact is largely unknown. Understand-
ing these phenomena and their interactions is of great
importance because interventions focusing on these vulner-
abilities could ultimately lead to targeted prevention
measures.
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